Pegfilgrastim regulatory update

FDA accepted for review an application from Apotex for pegfilgrastim, a biosimilar of neutropenia drug Neulasta pegfilgrastim from Amgen Inc. (NASDAQ:AMGN, Thousand Oaks, Calif.). Neulasta is a long...